Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Approvals Analysis: Abbott Leads Another Strong Month For Novel Approvals

Executive Summary

Abbott Laboratories accounted for two of five original PMA approvals recorded by US FDA in August. That update and more from Medtech Insight's Approvals Tracker.


Related Content

ACC 2018 Preview: Zoll's LifeVest, Abbott's HeartMate 3 And Amplatzer, Late-Breaking Trial Devices
Medtech's High-Earners: 2016 Executive Payouts Boosted By Bonuses, Stock Awards
US Approvals Analysis: Cook Churns Out 510(k)s In Q3
Abbott Pulls Absorb Stent Off The Market, Citing Low Sales
Celgene, Agios Ready For Enasidenib Launch After Early Approval
US Approvals Analysis: 2016 Another Record Year For FDA Novel Device Approvals
Medtronic Set To Compete With Abbott/St Jude In VADs After Buying HeartWare
Next-Gen HeartMate Launches In St. Jude's Portfolio


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts